Obstructive Sleep Apnea Clinical Trials

57 studies are recruiting for obstructive sleep apnea in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Boston, Massachusetts 7 Ann Arbor, Michigan 6 Cincinnati, Ohio 6 Atlanta, Georgia 4 Detroit, Michigan 4 New York, New York 4 Philadelphia, Pennsylvania 4 Austin, Texas 3 Chicago, Illinois 3 Dallas, Texas 3 La Jolla, California 3 Miami, Florida 3 Norfolk, Virginia 3 Pittsburgh, Pennsylvania 3 Rochester, Minnesota 3

Studies, page 3

  1. Down Syndrome Obstructive Sleep Apnea

    The purpose of this study is to assess whether oxygen supplementation during sleep improves working memory and other clinical and patient-reported outcomes among children who have Down Syndrome (DS) with moderate to severe Obstructive Sleep Apnea (OSA).

    Stage
    Phase 2
    Ages
    5 to 18
    Site
    Children's Hospital of Los Angeles, Los Angeles, California
    Locations
    7 in total
    Run by
    Brigham and Women's Hospital

    See if you can join NCT06043440 on ClinicalTrials.gov

  2. Pediatric Post-Approval Registry

    This registry is a prospective, multi-center, single-arm study of pediatric subjects (ages 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) System for the treatment of moderate or severe obstructive sleep apnea (OSA). Implanted subjects will be followed for 5 ye…

    Stage
    Not phased
    Ages
    18 to 21
    Site
    Childrens Hospital of Colorado, Aurora, Colorado
    Locations
    8 in total
    Run by
    Inspire Medical Systems, Inc.

    See if you can join NCT04457154 on ClinicalTrials.gov

  3. Trazodone on OSA Endotypes

    Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. Some OSA patients with low arousal threshold wake up prematurely during an obstructive event and do not have time for spontaneous upper airway (UA) dilator muscle recruitment. As a consequen…

    Stage
    Phase 1
    Ages
    21 to 70
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Brigham and Women's Hospital

    See if you can join NCT06286189 on ClinicalTrials.gov

  4. Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA

    Maxillomandibular advancement (MMA) surgery, one of the most successful surgical procedures for the treatment of obstructive sleep apnea (OSA), is predominantly used to manage patients with moderate to severe OSA. However, limiting factors include incomplete response in some cases, unfavorable faci…

    Stage
    Not phased
    Ages
    30 to 65
    Site
    Michigan Medicine Oral and Maxillofacial Surgery, Ann Arbor, Michigan
    Run by
    University of Michigan

    See if you can join NCT03929549 on ClinicalTrials.gov

  5. SUNOSI® (Solriamfetol) Pregnancy Registry

    The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).

    Stage
    Not phased
    Ages
    Any age
    Site
    Evidera, a PPD business unit, Morrisville, North Carolina
    Locations
    2 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT06413420 on ClinicalTrials.gov

  6. Time Restricted Eating in Sleep Apnea

    Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose levels and diabetes, obesity, and nonalcoholic fatty liver. While continuous positive airway pressure (CPAP), the best av…

    Stage
    EARLY_Phase 1
    Ages
    18 to 70
    Site
    University of California San Diego (ACTRI), La Jolla, California
    Run by
    University of California, San Diego

    See if you can join NCT06047496 on ClinicalTrials.gov

  7. Pharmacological Activation of HMN for OSA Aim 2

    Obstructive sleep apnea (OSA) is common and has major health implications but treatment options are limited. OSA patients show a marked reduction in upper airway (UA) dilator muscle activity at sleep onset and this phenomenon leads to increased collapsibility of UA compared to normal subjects. In t…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Brigham and Women's Hospital

    See if you can join NCT03858751 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.